Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays

References

• Lieberman SM, DiLorenzo TP. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens. 2003; 62:359–377.
   PubMedGoogle Scholar
• Tsai S, Shameli A, Santamaria P. CD8+T cells in type 1 diabetes. Adv Immunol. 2008; 100:79–124.
   PubMed Web of Science ®Google Scholar
• Liblau RS, Wong FS, Mars LT, Santamaria P. Autoreactive CD8 T cells in organ-specific autoimmunity: Emerging targets for therapeutic intervention. Immunity. 2002; 17:1–6.
   PubMed Web of Science ®Google Scholar
• Walter U, Santamaria P. CD8+T cells in autoimmunity. Curr Opin Immunol. 2005; 17:624–631.
   PubMed Web of Science ®Google Scholar
• Baker C, Petrich de Marquesini LG, Bishop AJ, Hedges AJ, Dayan CM, Wong FS. Human CD8 responses to a complete epitope set from preproinsulin: Implications for approaches to epitope discovery. J Clin Immunol. 2008; 28:350–360.
   PubMed Web of Science ®Google Scholar
• Mallone R, Martinuzzi E, Blancou P, Novelli G, Afonso G, Dolz M, Bruno G, Chaillous L, Chatenoud L, Bach JM, van Endert P. CD8+T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes. 2007; 56:613–621.
   PubMed Web of Science ®Google Scholar
• Rathmann S, Rajasalu T, Rosinger S, Schlosser M, Eiermann T, Boehm BO, Durinovic-Bello I. Preproinsulin-specific CD8+T cells secrete IFNgamma in human type 1 diabetes. Ann NY Acad Sci. 2004; 1037:22–25.
   PubMed Web of Science ®Google Scholar
• Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, Connan F, Dubois-Laforgue D, Caillat-Zucman S, Guillet JG, Carel JC, . Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci USA. 2005; 102:10581–10586.
   PubMed Web of Science ®Google Scholar
• Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM. Identification of naturally processed HLA-A2—Restricted proinsulin epitopes by reverse immunology. Diabetes. 2005; 54:2053–2059.
   PubMed Web of Science ®Google Scholar
• Ou D, Jonsen LA, Metzger DL, Tingle AJ. CD4+ and CD8+T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility. Hum Immunol. 1999; 60:652–664.
   PubMed Web of Science ®Google Scholar
• Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med. 1995; 181:1923–1927.
   PubMed Web of Science ®Google Scholar
• Panagiotopoulos C, Qin H, Tan R, Verchere CB. Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes. 2003; 52:2647–2651.
   PubMed Web of Science ®Google Scholar
• Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Greenbaum CJ, Pihoker C, Nepom GT. Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes. 2006; 55:3061–3067.
   PubMed Web of Science ®Google Scholar
• Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes. Diabetes. 2006; 55:3068–3074.
   PubMed Web of Science ®Google Scholar
• Wijesekara N, Chimienti F, Wheeler MB. Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab. 2009; 11 Suppl. 4: 202–214.
   PubMedGoogle Scholar
• Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA. 2007; 104:17040–17045.
   PubMed Web of Science ®Google Scholar
• Wenzlau JM, Hutton JC, Davidson HW. New antigenic targets in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008; 15:315–320.
   PubMedGoogle Scholar
• Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, Rankinen T, Bouchard C, Perusse L. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol. 2009; 46:217–226.
   PubMed Web of Science ®Google Scholar
• Fu Y, Tian W, Pratt EB, Dirling LB, Shyng SL, Meshul CK, Cohen DM. Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. PLoS One. 2009; 4:e5679.
   Web of Science ®Google Scholar
• Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007; 8:657–662.
   PubMed Web of Science ®Google Scholar
• Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, Rewers M, Eisenbarth GS, Yu L. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab. 2007; 92:88–92.
   PubMed Web of Science ®Google Scholar
• Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 1994; 152:163–175.
   PubMed Web of Science ®Google Scholar
• Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics. 1999; 50:213–219.
   PubMed Web of Science ®Google Scholar
• Valmori D, Gervois N, Rimoldi D, Fonteneau JF, Bonelo A, Lienard D, Rivoltini L, Jotereau F, Cerottini JC, Romero P. Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide. J Immunol. 1998; 161:6956–6962.
   PubMedGoogle Scholar
• Wong FS, Visintin I, Wen L, Flavell RA, Janeway CAJr. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med. 1996; 183:67–76.
   PubMed Web of Science ®Google Scholar
• Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R. The frequency and immunodominance of islet-specific CD8+T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes. 2008; 57:1312–1320.
   PubMed Web of Science ®Google Scholar
• Slansky JE, Rattis FM, Boyd LF, Fahmy T, Jaffee EM, Schneck JP, Margulies DH, Pardoll DM. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity. 2000; 13:529–538.
   PubMed Web of Science ®Google Scholar
• Chen W, Khilko S, Fecondo J, Margulies DH, McCluskey J. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med. 1994; 180:1471–1483.
   PubMed Web of Science ®Google Scholar
• Feltkamp MC, Vierboom MP, Kast WM, Melief CJ. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol Immunol. 1994; 31:1391–1401.
   PubMed Web of Science ®Google Scholar
• Keogh E, Fikes J, Southwood S, Celis E, Chesnut R, Sette A. Identification of new epitopes from four different tumor-associated antigens: Recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity. J Immunol. 2001; 167:787–796.
   PubMed Web of Science ®Google Scholar
• Tourdot S, Scardino A, Saloustrou E, Gross DA, Pascolo S, Cordopatis P, Lemonnier FA, Kosmatopoulos K. A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: Implication in the identification of cryptic tumor epitopes. Eur J Immunol. 2000; 30:3411–3421.
   PubMed Web of Science ®Google Scholar
• Shao H, Peng Y, Liao T, Wang M, Song M, Kaplan HJ, Sun D. A shared epitope of the interphotoreceptor retinoid-binding protein recognized by the CD4+ and CD8+ autoreactive T cells. J Immunol. 2005; 175:1851–1857.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Honeyman MC, Harrison LC. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific. Clin Immunol. 2001; 99:360–364.
   PubMed Web of Science ®Google Scholar
• van der Burg SH, Visseren MJ, Brandt RM, Kast WM, Melief CJ. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol. 1996; 156:3308–3314.
   PubMed Web of Science ®Google Scholar
• Lipford GB, Bauer S, Wagner H, Heeg K. In vivo CTL induction with point-substituted ovalbumin peptides: Immunogenicity correlates with peptide-induced MHC class I stability. Vaccine. 1995; 13:313–320.
   PubMed Web of Science ®Google Scholar
• Tarpey I, Stacey S, Hickling J, Birley HD, Renton A, McIndoe A, Davies DH. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif. Immunology. 1994; 81:222–227.
   PubMed Web of Science ®Google Scholar
• Dogra RS, Vaidyanathan P, Prabakar KR, Marshall KE, Hutton JC, Pugliese A. Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia. 2006; 49:953–957.
   PubMed Web of Science ®Google Scholar
• Wilson DB. Immunology: Insulin auto-antigenicity in type 1 diabetes. Nature. 2005; 438 E5: E5–E6.
   Google Scholar
• Alleva DG, Crowe PD, Jin L, Kwok WW, Ling N, Gottschalk M, Conlon PJ, Gottlieb PA, Putnam AL, Gaur A. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest. 2001; 107:173–180.
   PubMed Web of Science ®Google Scholar
• Durinovic-Bello I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliott J, Roep BO, Karges W, Boehm BO. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes. Diabetologia. 2004; 47:439–450.
   PubMed Web of Science ®Google Scholar
• Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445:881–885.
   PubMed Web of Science ®Google Scholar